Filter Results:
(624)
Show Results For
- All HBS Web
(624)
- People (2)
- News (57)
- Research (449)
- Events (2)
- Multimedia (8)
- Faculty Publications (395)
Show Results For
- All HBS Web
(624)
- People (2)
- News (57)
- Research (449)
- Events (2)
- Multimedia (8)
- Faculty Publications (395)
- August 2007
- Article
Financial Contracting in Biotech Strategic Alliances
Robinson, David, and Toby E. Stuart. "Financial Contracting in Biotech Strategic Alliances." Journal of Law & Economics 50, no. 3 (August 2007): 559–596.
- May 1992 (Revised February 1996)
- Teaching Note
Nucleon, Inc., Teaching Note
By: Gary P. Pisano
Teaching Note for (9-692-041). View Details
Keywords: Biotechnology Industry
- October 1994 (Revised November 1994)
- Case
DNA Plant Technology Corporation (DNAP)
By: Ray A. Goldberg and Quintus Travis
Keywords: Biotechnology Industry
Goldberg, Ray A., and Quintus Travis. "DNA Plant Technology Corporation (DNAP)." Harvard Business School Case 595-044, October 1994. (Revised November 1994.)
- November 1985
- Case
Genetics Institute Enters the Seed Business
By: Ray A. Goldberg and Michael Joseph Kennedy
Goldberg, Ray A., and Michael Joseph Kennedy. "Genetics Institute Enters the Seed Business." Harvard Business School Case 586-077, November 1985.
- November 1978 (Revised February 1990)
- Case
Amicon Corp. (C)
Details the negotiations between Amicon and one potential licensee, Jackson. View Details
Keywords: Technology; Patents; Negotiation Process; Negotiation Participants; Health Care and Treatment; Biotechnology Industry
Capon, Noel. "Amicon Corp. (C)." Harvard Business School Case 579-095, November 1978. (Revised February 1990.)
- 20 May 2013
- Op-Ed
Making America an Industrial Powerhouse Again
computer science, optics, and various engineering disciplines. We need to get over the outdated notion that manufacturing is "mature" and unconnected to science. Anyone who believes that should take a tour of a factory that produces semiconductors or View Details
- 01 Jun 2000
- News
Seeing the Light
Living in Los Angeles and working as a marketer for a global biotechnology firm, Jana Kirlin Brownell (MBA '83) saw her career path take an unexpected turn. More than once, her father had asked her to come home and take over the Kirlin... View Details
- 01 Mar 2004
- News
The Business of Babies
surrogate mother have the right to change her mind and keep the baby she’s carrying?) and the political climate becomes more accepting of the role science can play in creation (with cloning the most radical example), the market cannot thrive. “If advances in View Details
- Web
Collection Highlights | Baker Library
in the financing of the transcontinental railroad and development of the electrical industry. Henri A. Termeer Papers Document the career of an entrepreneur and biotechnology executive known for leading Genzyme Corporation from 1983 to... View Details
- 01 Jun 2000
- News
Managing the Map
We are at the dawn of a new epoch in the world of science, one that will cast strong light on a unique corner of the biotechnology field known as genomics. The designation refers to the study of genes, those chemical building blocks of... View Details
Keywords: Peter K. Jacobs
- 01 Dec 2017
- News
Removing Barriers
people from different parts of the world, she notes, is extremely valuable. Prior to coming to HBS, Anita earned a degree in biotechnology and biochemical engineering from the Indian Institute of Technology Kharagpur and then worked in... View Details
- 05 Dec 2013
- Op-Ed
Encourage Breakthrough Health Care by Competing on Products Rather Than Patents
Like many people interested in the tangled connections between health care progress and intellectual property rights, I avidly followed the Myriad Genetics case, decided by the Supreme Court this June 13. In sum, molecular diagnostics maker Myriad sought "the... View Details
- 26 Jul 2024
- Research & Ideas
Why Great Ideas Get Stuck in Universities
Entrepreneurs must overcome many barriers to get discoveries to market, but academic researchers face an additional one they might not realize: themselves. Academics tend to develop a myopic focus on the unique expertise they spend their lives developing, but that... View Details
- May 1999
- Teaching Note
Elliot Lebowitz TN
By: Paul A. Gompers
Teaching Note for (9-297-094). View Details
Keywords: Biotechnology Industry
- January 1998 (Revised September 2001)
- Case
Genset: 1989
By: Paul A. Gompers and Amy Burroughs
Discusses the start-up strategy at Genset, a French biotech firm. Pascal Brandys, a venture capitalist, and Marc Vasseur, a leading French scientist, must decide how to proceed. Future real options are central to the strategy. View Details
Gompers, Paul A., and Amy Burroughs. "Genset: 1989." Harvard Business School Case 298-070, January 1998. (Revised September 2001.)
- June 1997 (Revised September 1997)
- Case
Genset Initial Public Offering (B)
By: Paul A. Gompers and Jeffrey M. Anapolsky
Supplements the (A) case. View Details
Keywords: Business Model; Initial Public Offering; Genetics; Going Public; Management Teams; Biotechnology Industry; France; United States
Gompers, Paul A., and Jeffrey M. Anapolsky. "Genset Initial Public Offering (B)." Harvard Business School Case 297-097, June 1997. (Revised September 1997.)
- March 2018 (Revised July 2018)
- Case
Greenlight Biosciences: In Search of Impact Investment
By: Michael Chu, Annelena Lobb and Joni Coughlin
Greenlight Biosciences, a biotech company, is in search of impact investment for its next round of financing. View Details
Keywords: Impact Investment; Investment; Environmental Sustainability; Financing and Loans; Biotechnology Industry
Chu, Michael, Annelena Lobb, and Joni Coughlin. "GreenLight Biosciences: In Search of Impact Investment." Harvard Business School Case 318-072, March 2018. (Revised July 2018.)
- November 2016
- Case
Anthony Starks at InSiL Therapeutics (A)
By: Gary Pisano and Vicki Sato
When Bruce Wayne hired Anthony Starks, he thought he had hit a home run by getting the most brilliant and passionate scientist-leader in the field to be his CSO. But a few months in, Wayne and Starks begin to clash over crucial forward-looking decisions about the... View Details
Keywords: Biotech; Silicon; Managing Innovation; Management Challenges; Managing People; Managing Organization; R＆D; R＆D Project Management; Platform; Venture Capital; Drug Discovery; management; Biotechnology Industry; California
Pisano, Gary, and Vicki Sato. "Anthony Starks at InSiL Therapeutics (A)." Harvard Business School Case 617-029, November 2016.
- January 2012 (Revised August 2012)
- Case
Dirigo International
By: Christopher M. Gordon and Chad M. Carr
Dirigo International is proposing a major expansion of their life sciences research and manufacturing facilities in the heart of a major city and middle to lower income residential neighborhood. The company and city government are seeking a development solution in the... View Details
Keywords: Production; Property; Expansion; Governing Rules, Regulations, and Reforms; Business and Government Relations; Research and Development; Outcome or Result; Biotechnology Industry
Gordon, Christopher M., and Chad M. Carr. "Dirigo International." Harvard Business School Case 212-056, January 2012. (Revised August 2012.)
- August 2010 (Revised August 2012)
- Supplement
Generation Health: A Pioneer in Genetics Benefit Management (B)
By: Robert F. Higgins
Higgins, Robert F. "Generation Health: A Pioneer in Genetics Benefit Management (B)." Harvard Business School Supplement 811-005, August 2010. (Revised August 2012.)